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Background and objectives:  
Nowadays a high amount of pre/probiotic studies use metagenomics to control the effectiveness of 
the use of pre/probiotic. Many bacterial species are non-cultivable out of their natural environment 
and, therefore, some sets of species can only be studied all together within their environment (e.g. 
human gut) using metagenomics, sampling and sequencing DNA from all species. Sample size in 
metagenomics is an unresolved problem in which statistics and computational methods have much 
to say, especially from the point of view of Bayesian approach. One possibility is the use of a 
bietapic method: conduct a pilot study, prior to the final study. 
Methodology:  
We propose the use of a Bayesian method based on Markov Chain Monte Carlo simulations 
(MCMC) to calculate the richness, supposing a Dirichlet-multinomial probability distribution for 
the matrix of richness-abundance. The sample size on the base of sampling effort (90, 95 and 99%) 
is then calculated assuming saturation or not using parametric and non-parametric nonlinear 
models.  
Results and conclusions:  
These calculations have been implemented in the new library ‘BDSbiost3’ for R, which has been 
used in different simulation scenarios of the common practice in metagenomics (low abundance, 
high richness, oversampling, under sampling) and the results (Sp) are presented with the effort 
curve and a value proposed of the correct number of samples to reach the extrapolated richness of 
the 90, 95 and 99%. This function can help researchers in pre/probiotics to better design studies and 
save on number of samples. 
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